SCHEMBL702

SCHEMBL702

CCn1c2c(c3ccccc31)C(=O)N(Cc1nc[nH]c1C)CC2

nearest known ligand 0.78

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 2/20 0.78
HTR3A P46098 2/20 0.78
CYP1A2 P05177 1/20 0.78
CYP3A4 P08684 1/20 0.78
ADRA2C P18825 1/20 0.78
HTR2A P28223 1/20 0.78
HTR2C P28335 1/20 0.78
ADRA1A P35348 1/20 0.78
HTR2B P41595 1/20 0.78
CASP6 P55212 1/20 0.76
CD44 P16070 1/20 0.42
HTR3E A5X5Y0 1/20 0.37
HTR3B O95264 1/20 0.37
HTR3D Q70Z44 1/20 0.37
HTR3C Q8WXA8 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fumaric Acid SCHEMBL582 0.93 KCNH2 (0.68) KCNH2HTR3ACYP1A2CYP3A4ADRA2C
Maleic Acid SCHEMBL581 0.93 KCNH2 (0.68) KCNH2HTR3ACYP1A2CYP3A4ADRA2C
SCHEMBL981 0.92 KCNH2 (0.78) KCNH2HTR3ACYP1A2CYP3A4ADRA2C
SCHEMBL766 0.90 KCNH2 (0.75) KCNH2HTR3ACYP1A2CYP3A4ADRA2C
SCHEMBL7319453 0.88 KCNH2 (0.72) KCNH2HTR3ACYP1A2CYP3A4ADRA2C
SCHEMBL803 0.88 KCNH2 (0.72) KCNH2HTR3ACYP1A2CYP3A4ADRA2C
Alosetron SCHEMBL631 0.88 KCNH2 (1.00) KCNH2HTR3ACYP1A2CYP3A4ADRA2C
Alosetron SCHEMBL29377019 0.88 KCNH2 (1.00) KCNH2HTR3ACYP1A2CYP3A4ADRA2C
SCHEMBL1214 0.87 KCNH2 (0.70) KCNH2HTR3ACYP1A2CYP3A4ADRA2C
Alosetron SCHEMBL806 0.87 CASP6 (1.00) KCNH2HTR3ACYP1A2CYP3A4ADRA2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5360800-A Tetrahydro-1H-pyrido[4,3-b]indol-1-one derivatives GLAXO GROUP LIMITED (GB) 1994-11-01 US claimed
US-5276050-A Administering for treatment of bulemia or seasonal affective disorder GLAXO GROUP LIMITED (GB) 1994-01-04 US disclosed
US-5225407-A Cognition activators GLAXO GROUP LIMITED (GB) 1993-07-06 US disclosed
EP-0450757-A2 Use of 5-hydroxytryptamine-antagonists in the treatment of mental disorders originating in childhood GLAXO GROUP LIMITED (GB) 1991-10-09 EP disclosed